Chart Analysis AI1 Daily Timeframe Chart as of 23 April 2026
AI1 Announcement Overview
Adisyn Ltd (ASX: AI1) has secured firm commitments to raise A$14 million through an institutional placement at A$0.0675 per share, issuing approximately 207.4 million new shares. The raise was cornerstoned by two major institutional investors — Regal Funds Management (A$20B+ AUM) and Meitav (~A$190B AUM), Israel's largest investment house. Chairman Kevin Crofton and Non-Executive Director Dominic O'Hanlon will also participate with a combined $200,000, subject to shareholder approval.
The placement follows two back-to-back technology milestones: a breakthrough in low-temperature graphene deposition for semiconductor interconnects, and an exclusive worldwide licence for graphene-based radar absorption technology from Tel Aviv University. Both milestones were announced within the same week, providing a strong catalyst for the capital raise.
Announcement Type: Capital Raising — Institutional Placement | Technology Milestone | Licence Agreement
Key Details at a Glance
| Detail | Value |
|---|---|
| Raise Amount | A$14,000,000 |
| Issue Price | A$0.0675 per share |
| New Shares Issued | ~207.4 million |
| Discount to Last Close | 10% (last close A$0.075 on 21 Apr) |
| Discount to 15-Day VWAP | 5.78% |
| Cornerstone Investors | Regal Funds Management, Meitav |
| Director Participation | $200,000 (subject to approval) |
| Settlement Date | 29 April 2026 |
| Allotment Date | 30 April 2026 |
| Lead Manager | Sandton Capital Advisory (6% fee) |
Dilution Impact on AI1 Shareholders
The placement will issue ~207.4 million new shares under existing Listing Rules 7.1 and 7.1A capacity, meaning no shareholder vote is required for the placement itself. Based on approximately 834 million shares currently on issue, this represents a ~24.9% increase in total share count. Existing shareholders who do not participate will see their holdings diluted by approximately 19.9% on a post-raise basis.
Importantly, there is no Share Purchase Plan (SPP) announced at this stage. This means retail investors do not currently have an opportunity to participate at the placement price of A$0.0675, which may frustrate longer-term holders. Investors should monitor for any subsequent SPP announcement, which would allow existing shareholders to subscribe for new shares, typically at the same or similar price to the placement.
Use of Proceeds
Proceeds from the placement will be directed toward:
- Graphene technology advancement — funding the progression from lab-scale demonstration to film optimisation, repeatability testing, and wafer-level scale-up for semiconductor interconnects, as well as advancing the radar absorption research program under the Tel Aviv University licence.
- Business development — initiating commercial engagement with global semiconductor leaders and defence industry partners.
- Working capital — general corporate purposes and operational expenses.
- Offer costs — including the 6% management fee payable to Sandton Capital Advisory, estimated at approximately A$840,000.
A notable portion of the capital is allocated to pre-revenue R&D activities. No specific dollar breakdown was provided between the categories, which is common for early-stage technology companies but worth noting for investors tracking capital allocation.
Investor & Institutional Backing
The quality of the placement participants is a standout feature of this raise and provides a strong signal for the broader market:
- Regal Funds Management — one of Australia's most active institutional investors, managing over A$20 billion across equities, resources, and alternatives. Regal has deep expertise in technology and defence sectors and does not typically participate in micro-cap placements without conducting significant technical and commercial due diligence.
- Meitav — Israel's largest investment house, managing approximately A$190 billion on behalf of over one million clients. Their participation brings an international institutional lens and may reflect particular confidence in the defence and stealth technology pathway, given Israel's globally recognised expertise in defence innovation.
- Director participation — Chairman Kevin Crofton and NED Dominic O'Hanlon subscribing $200,000 of their own capital (subject to shareholder approval at a General Meeting expected ~June 2026) signals board-level conviction and insider alignment with the company's direction.
The combined AUM of the cornerstone investors exceeds A$210 billion, which is highly unusual for an ASX micro-cap placement and provides meaningful external validation of Adisyn's graphene technology platform and commercial potential.
Catalysts & Strategic Context
The placement was strategically timed to follow two significant technology milestones announced within a single week, giving the company strong narrative momentum heading into the raise:
1. Semiconductor Graphene Breakthrough (20 April 2026)
Through its wholly-owned subsidiary 2D Generation, Adisyn demonstrated graphene formation at semiconductor-compatible temperatures using an industrial Atomic Layer Deposition (ALD) system. This result simultaneously achieved three criteria the semiconductor industry has been unable to combine until now: use of an industrial ALD system, operation within semiconductor thermal limits (~450°C), and continuous graphene layer formation on a 1cm² coupon.
Copper interconnects — the wiring connecting billions of transistors inside advanced chips — are widely regarded as one of the most critical bottlenecks constraining chip performance, energy efficiency, and further scaling below 2nm design nodes. Graphene has long been identified as a potential replacement material, but integrating it within existing fabrication environments has remained elusive. Adisyn's result positions the company to enter industry collaboration and commercial engagement with global semiconductor leaders.
The addressable market is substantial — the global semiconductor industry is forecast to reach approximately US$1 trillion by 2030, with AI-driven demand for high-performance chips accelerating the need for advanced interconnect solutions.
2. Stealth Drone Technology Licence (22 April 2026)
Adisyn's subsidiary 2D Radar Absorbers secured an exclusive worldwide licence from Ramot (Tel Aviv University's technology transfer company) for graphene-based radar absorption technology. Laboratory testing has demonstrated approximately 20dB radar absorption — equivalent to a 100-fold reduction in radar return signal — with ongoing optimisation targeting approximately 30dB reduction, which would equate to a 1,000-fold decrease. At that level, a standard 1m² drone radar signature would become equivalent in detectability to a butterfly.
Unlike conventional radar-absorbing materials, graphene-enhanced composites combine structural strength with inherent stealth properties, removing the need for additional coatings and enabling lightweight, high-performance UAV designs. The structured 12-month research program is expected to cost less than A$100,000, making it a capital-efficient pathway to further development.
The global military drone market is projected to grow from US$20.7 billion in 2026 to US$66.5 billion by 2035, with stealth capability becoming increasingly mission-critical across drones, loitering munitions, and other autonomous defence platforms.
AI1 Market Sentiment — How the Market Reacted
Price Reaction
The AI1 share price surged +80.0% on announcement day, closing at A$0.135 versus a previous close of A$0.075. This is a decisive bullish reaction — the market is clearly pricing in the combined value of the institutional backing and dual technology catalysts well beyond any dilution concerns.
Placement Price vs Market Price
The current price of A$0.135 represents a 100% premium to the placement price of A$0.0675. This gap indicates the market believes the cornerstone investors secured shares at a significant discount to perceived fair value, and that the catalysts driving the raise have materially re-rated the stock. Placement participants are sitting on a 100% paper gain before shares have even been allotted.
Volume Context
The +80% single-day move on a trading halt resumption suggests extremely elevated volume relative to AI1's average daily turnover (~4.8 million shares). A volume spike of this magnitude confirms strong conviction behind the price action rather than a thin-liquidity driven spike that could easily reverse.
Buyer vs Seller Dynamics
AI1 closing near its session highs at A$0.135 — against a 52-week high of A$0.145 — suggests buyers dominated throughout the session with limited selling pressure. There is no sign of an early morning spike followed by a selloff, which would have indicated profit-taking or distribution. Instead, this is sustained demand throughout the trading day.
Broader Market Context
This move is occurring on the back of two genuine technology milestones and institutional validation from globally recognised fund managers, not speculative retail-driven hype. The dual catalyst structure — semiconductor + defence — gives the stock two independent re-rating pathways, which broadens the potential investor base beyond typical ASX micro-cap speculators.
Sentiment Verdict
Strongly Bullish. An 80% single-day move backed by institutional cornerstone investors with combined AUM exceeding A$210B, trading at 2x the placement price, and closing near 52-week highs represents a clear market endorsement of both the catalysts and the capital raise. The key question going forward is whether AI1 can sustain above the A$0.096 support level once the initial momentum fades and new shares are allotted on 30 April.
Risks & Considerations
- Pre-revenue technology — both the semiconductor and defence programs are early-stage with no commercial revenue or binding offtake agreements. The timeline from lab demonstration to industry partnerships and recurring revenue is genuinely uncertain and could take years.
- Dilution — a ~25% increase in share count is material, particularly without an accompanying SPP for retail shareholders. Further capital raises are possible given the company's ongoing losses.
- Execution risk — scaling graphene deposition from a 1cm² coupon to full wafer-level manufacturing involves significant technical hurdles. Repeatability, yield, and integration with existing semiconductor fabrication processes are yet to be proven at scale.
- Capital burn — FY2025 revenue declined 50.5% to A$3.48M, and the company reported net losses of A$9.6M. The A$14M raise provides near-term runway, but further capital may be needed if milestones take longer than anticipated.
- Micro-cap volatility — with a market cap around A$60–70M post-raise, AI1 remains a micro-cap subject to high volatility, wide bid-ask spreads, and liquidity risk. An 80% single-day move highlights this risk in both directions.
- Offer costs — the 6% management fee (~A$840K) is standard for placements of this size but consumes a meaningful portion of a A$14M raise for a company with limited revenue.
Key Dates & Timeline
| Date | Event |
|---|---|
| 20 April 2026 | Graphene semiconductor breakthrough announced |
| 22 April 2026 | Stealth drone technology licence announced |
| 23 April 2026 | Placement announced, trading resumes on ASX |
| 29 April 2026 | Settlement of new shares via DVP |
| 30 April 2026 | Allotment of new shares |
| ~June 2026 | General meeting for approval of director participation |
AI1 Price Action Analysis
AI1 is trading at A$0.135, up 80% on the session and approaching its 52-week high of A$0.145. The stock has moved from the lower end of its 52-week range (low of A$0.038) to near the top in a single session, driven entirely by the announcement catalyst.
Key levels to watch:
- Resistance: A$0.135–0.145 — current price is testing 52-week highs. A sustained break above A$0.145 would put AI1 into fresh highs with no overhead resistance, potentially attracting momentum-driven buyers.
- Support (S1): A$0.096 — a pullback to this level would represent a natural retracement and a zone where buyers may look to step back in. This is the first level to watch for a potential higher low formation.
- Support (S2): A$0.080 — a deeper pullback level that aligns with prior consolidation activity and could attract value-oriented buyers.
- Support (S3): A$0.0675 — the placement price itself. If AI1 were to trade back to this level, it would signal the market has fully unwound the announcement premium and placement participants are underwater.
The gap between the previous close of A$0.075 and today's opening price creates a price gap on the daily chart that may act as a magnet for any short-term retracement. Traders should watch whether the stock can hold above A$0.096 in the coming sessions, particularly around the 30 April allotment date when new shares become tradeable.
Key Takeaways
- Institutional validation is the headline — Regal and Meitav don't participate in micro-cap placements without meaningful due diligence. Their combined A$210B+ AUM backing a A$14M raise is a powerful signal that should not be overlooked.
- Dual catalysts broaden the opportunity — semiconductor interconnects and defence stealth materials give AI1 two independent pathways to commercialisation across two structurally growing global markets.
- Market response is emphatic — an 80% single-day move and a 100% premium to placement price reflects strong conviction, but also sets high expectations for future milestone delivery.
- Dilution is real but manageable — the ~25% share count increase is material, but the quality of participants and the significance of the technology milestones offset the dilution concern in the near term.
- Watch the A$0.096 level — how AI1 behaves around first support after the initial momentum subsides will indicate whether this re-rating has staying power or was a one-day event.
Summary
Adisyn (ASX: AI1) raised A$14 million at A$0.0675 per share through an institutional placement cornerstoned by Regal Funds Management (A$20B+ AUM) and Meitav (~A$190B AUM), with director participation of $200,000 subject to shareholder approval. The raise follows two technology milestones announced in the same week — a graphene semiconductor interconnect breakthrough via its 2D Generation subsidiary and an exclusive worldwide licence for graphene-based radar absorption technology from Tel Aviv University targeting the fast-growing military drone market.
The market responded decisively, with AI1 surging 80% to A$0.135 on announcement day, trading at a 100% premium to the placement price. The placement introduces ~24.9% dilution with no SPP announced for retail investors. New shares settle on 29 April and are allotted on 30 April 2026.
Both technology programs remain pre-revenue with uncertain commercialisation timelines, but the institutional validation from two globally recognised fund managers with combined AUM exceeding A$210 billion is a significant credibility signal. The key level to watch is A$0.096 — how AI1 behaves around this first support after the initial momentum fades will determine whether the re-rating has staying power.
This analysis is for informational purposes only and does not constitute financial advice. Always conduct your own research or consult a licensed financial adviser before making investment decisions.